AZD-3199
Showing 1 - 25 of 27
Triple-negative Metastatic Breast Cancer Trial in Boston (Cisplatin, AZD1775)
Completed
- Triple-negative Metastatic Breast Cancer
-
Boston, MassachusettsDana-Farber Cancer Institute
Oct 29, 2021
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)
Completed
- Advanced Gastric Adenocarcinoma
-
Seoul, Korea, Republic ofSamsung Medical center
Jun 13, 2022
Dementia, Alzheimer, Mild Cognitive Impairment Trial in Leicester (Cognitive Training)
Terminated
- Dementia
- +4 more
- Cognitive Training
-
Leicester, Leicestershire, United Kingdom
- +1 more
May 26, 2022
Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial
Completed
- Covid19
- +2 more
- Immunogenicity after first dose of participants who received first dose of ChAdox-1 n COV-19 vaccine
-
Bangkok, ThailandThananda Trakarnvanich
Jul 13, 2021
Advanced Gastric Cancer Trial in Seoul (AZD5363, paclitaxel)
Completed
- Advanced Gastric Cancer
-
Seoul, Seoul, Korea, Republic Of, Korea, Republic ofSamsung Medical Center
Dec 26, 2019
Small Cell Lung Cancer Trial in Seoul (AZD2811)
Terminated
- Small Cell Lung Cancer
-
Seoul, Korea, Republic ofSamsung Medical center
Nov 23, 2018
Chronic Idiopathic Urticaria Trial in Baltimore (AZD1981, Placebo)
Completed
- Chronic Idiopathic Urticaria
- AZD1981
- Placebo
-
Baltimore, MarylandJohns Hopkins Asthma and Allergy Center
Jun 13, 2017
Asthma, Airway Obstruction Trial in Denmark, Sweden (AZD3199, Formoterol, Placebo)
Advanced Solid Malignancies, Malignant Lymphoma Trial in Chuo-ku, Manchester, Surrey (AZD1208)
Completed
- Advanced Solid Malignancies
- Malignant Lymphoma
-
Chuo-ku, Japan
- +2 more
Oct 6, 2015
COPD (COPD). Trial in London (AZD4721, Placebo, AZD5069)
Completed
- Chronic Obstructive Pulmonary Disease (COPD).
- AZD4721
- +2 more
-
London, United KingdomResearch Site
Jun 24, 2015
Mucosal Melanoma, Recurrent Melanoma, Stage IV Melanoma Trial in Tampa (temsirolimus, selumetinib, laboratory biomarker
Terminated
- Mucosal Melanoma
- +2 more
- temsirolimus
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Apr 29, 2014
Parkinson's Disease Trial in London (AZD3241 ER formulation 1, Placebo, AZD3241 Alternative titration scheme with formulation 1
Completed
- Parkinson's Disease
- AZD3241 ER formulation 1
- +2 more
-
London, United KingdomResearch site
Aug 16, 2012
COPD, Lung Disease Trial in London (AZD3199, Moxifloxacin, Placebo comparator)
Completed
- Chronic Obstructive Pulmonary Disease
- Lung Disease
- AZD3199
- +2 more
-
London, UK, United KingdomResearch Site
Feb 15, 2011
COPD Trial in Worldwide (AZD1236, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- AZD1236
- Placebo
-
Russe, Bulgaria
- +13 more
Jul 25, 2011
Healthy Trial in Slough (AZD3199 Turbuhaler®, Placebo Turbuhaler®)
Completed
- Healthy
- AZD3199 Turbuhaler®
- Placebo Turbuhaler®
-
Slough, Berkshire, United KingdomResearch Site
May 4, 2009